The Swedish Environmental Classification and Information System for Pharmaceuticals - An empirical investigation of the motivations, intentions and expectations underlying its development and implementation

Environment International

Volumn 35, Issue 5, 2009, Pages 778-786

  Agerstrand M ^a   Wester, M ^a   Ruden C ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Classification; Ecotoxicity; Environmental hazard and risk assessment; Pharmaceuticals; SECIS; Self regulation; Survey study; The Swedish Environmental Classification and Information System for Pharmaceuticals; Unilateral commitment; Voluntary agreement; Voluntary approach

Indexed keywords

DRUG PRODUCTS; ENVIRONMENTAL REGULATIONS; INFORMATION SYSTEMS; MOTIVATION; RISK ASSESSMENT; SURVEYS;

ECOTOXICITY; ENVIRONMENTAL CLASSIFICATIONS; ENVIRONMENTAL HAZARDS; SECIS; SELF REGULATION; UNILATERAL COMMITMENT; VOLUNTARY AGREEMENT; VOLUNTARY APPROACH;

CLASSIFICATION (OF INFORMATION);

CLASSIFICATION; ECOTOXICOLOGY; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL HAZARD; INFORMATION SYSTEM; KNOWLEDGE; PHARMACEUTICAL INDUSTRY; RISK ASSESSMENT; SURVEY;

ARTICLE; DRUG CLASSIFICATION; DRUG INDUSTRY; DRUG INFORMATION; ECOTOXICITY; ENVIRONMENTAL PROTECTION; INFORMATION SYSTEM; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; SYSTEM ANALYSIS;

EID: 67349272605     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2008.12.001     Document Type: Article

References (30)

1. Anton W.R.Q., Deltas G., and Khanna M. Incentives for environmental self-regulation and implications for environmental performance. J Environ Econ Manage 48 (2004) 632-654
2. In: Bengtsson B.-E., Gunnarsson B., Wall T., and Wennmalm Å. (Eds). Environment and pharmaceuticals (2006), Apoteket AB
3. Börkey P., Glachnt M., and Lévêque F. Voluntary approaches for environmental policy in OECD countries: An assessment. Report from CERNA (Centre d'économie industrielle), Paris (1998)
4. Carlsson C., Johansson A.-K., Alvan G., Bergman K., and Kühler T. Are pharmaceuticals potent environmental pollutants? Part I: Environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 364 (2006) 67-87
5. Dawson N.L., and Segerson K. Voluntary agreements with industries: participation incentives with industry-wide targets (2003), University of Connecticut, Department of Economics Working Paper Series
6. Efpia (European Federation of Pharmaceutical Industries and Associations). The Pharmaceutical Industry in figures (2007), Brussels, Belgium
7. European Medicines Agency, EMEA. Committee for medicinal products for human use (CHMP). Guideline on the environmental risk assessment of medicinal products for human use (2006) 1 June 2006. Ref EMEA/CRMP/SWP/4447/00
8. European Commission. European Commission Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Part II, 2003 (2003). http://ecb.jrc.it/home.php?CONTENU=/Technical-Guidance-Document/sommaire.php (http://ecb.jrc.it/home.php?CONTENU=/Technical-Guidance-Document/sommaire.php)
9. European parliament and the council of the European union. Directive 2001/83/EC of the European parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use. Official journal (2001) 67-128 L-311, 28/11/
10. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76 (2006) 122-159
11. Gunningham N., and Sinclair D. Voluntary approaches to environmental protection: lessons from the mining and forestry sectors. Foreign direct investment and the environment: lessons from the mining sector (2002), OCED, Paris 157-185
12. Khanna M., and Damon L. EPA's voluntary 33/50 program: impact on toxic releases and economic performance of firms. J Environ Econ Manage 37 1 (1999) 1-25
13. In: Kümmerer K. (Ed). Pharmaceuticals in the environment: sources, fate, effects and risks (2004), Springer-Verlag ISBN: 3-540-41067-8
14. Lyon T.P., and Maxwell J.W. "Voluntary" approaches to environmental regulation: a survey. Kelley School of Business, Indiana University. In: Franzini M., and Nicita A. (Eds). Environmental economics: past present and future (1999), Aldershot, Hampshire
15. Mattson B. A voluntary environmental classification system for pharmaceutical substances. Drug Inf J 41 2 (2007) 187-191
16. Mattson B., Näsman I., and Ström J. Sweden's voluntary environmental drug classification system. Regul Aff J (2007) March
17. Maxwell J.W., Lyon T.P., and Hackett S.C. Self-regulation and social welfare: the political economy of corporate environmentalism. J Law Econ 43 2 (2000) 583-618
18. Nyborg K. Voluntary agreements and non-verifiable emissions. Environ Resour Econ 17 (2000) 125-144
19. OECD. Voluntary approaches for environmental policy: an assessment (1999), OECD, Paris ISBN: 9789264171312
20. OECD. Voluntary approaches for environmental policy: effectiveness, efficiency and usage in policy mixes (2003), OECD, Paris ISBN: 92-64-10177-2
21. Saaty R.W. The analytic hierarchy process and SWOT analysis - what it is and how it is used. Math Model 9 (1987) 161-178
22. Swedish Chemicals Agency (Kemikalieinspektionen). Swedish Chemical Agency's Code of Statutes (KIFS 2005:7) (2005)
23. Swedish Environmental Objectives Council. Progress report: Sweden's environmental objectives - in an interdependent world (2007)
24. Swedish Medical Product Agency (Läkemedelsverket). Report in Swedish, to the Swedish government: Miljöpåverkan från läkemedel samt kosmetiska och hygieniska produkter (2004) August
25. Swedish Medical Product Agency (Läkemedelsverket). Press release (in Swedish), 2005-10-10.
26. The Stockholm County Council (SLL). Press release (in Swedish), 2005-10-10.
27. The Swedish Association of Local Authorities and Regions (SKL). Press release (in Swedish), 2005-10-11.
28. The Swedish Association of the Pharmaceutical Industry (LIF). Environmental classification of pharmaceutical in fass.se - guidance to pharmaceutical companies (2007). http://www.fass.se/LIF/lakarbok/lakemedelhalsa_artikel.jsp?articleID=76074 http://www.fass.se/LIF/lakarbok/lakemedelhalsa_artikel.jsp?articleID=76074
29. Wennmalm Å., and Gunnarsson B. Public health care management of water pollution with pharmaceuticals: environmental classification and analysis of pharmaceutical residues in sewage water. Drug Inf J 39 (2005) 291-297
30. In: Williams R.T. (Ed). Human pharmaceuticals: assessing the impacts on aquatic ecosystems (2005), Society of Environmental toxicology and Chemistry (SETAC), Pensacola (FL), USA 400 pp.